This finding is supported by clinical data; for instance, in gastric cancer, high EGR1 expression correlates significantly with advanced tumor stage (Spearman’s ρ ~ 0.6, p < 0.001) and poor prognosis [130,131,132]. This evidence concerns the gene EGR1 and gastric cancer.